Examining Better Access demonstrates improvements in symptoms and wellbeing in consumers, suggesting ongoing monitoring is necessary.
Better Access is achieving reductions in symptoms and improvements in functioning and wellbeing for the majority of consumers. A minority of consumers do not have these sorts of positive outcomes, however, and further work is required to understand why. Routine measurement of outcomes - particularly consumer-rated outcomes - would enable ongoing monitoring of the extent to which Better Access is achieving its goals.
No takes yet. Share an insight, caveat, or question.
Pirkis et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: